Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Statement

9 Jun 2016 07:00

RNS Number : 6604A
PZ CUSSONS PLC
09 June 2016
 

9 June 2016

 PZ Cussons Plc

(the "Group")

 

Trading Update

 

PZ Cussons Plc, a leading consumer products group, today issues the following trading update for the year ended 31 May 2016.

 

Overview of financial performance and position

 

The board is pleased to announce that the performance of the Group for the year ended 31 May 2016 has been in line with expectations with performance in Europe and Asia offsetting more difficult trading conditions in Africa.

The financial position of the Group remains strong with cash generation also in line with expectations.

 

Trading Update

 

Europe

 

In the UK washing and bathing division, all brands have performed strongly driven by a continuous programme of renovation and innovation. The Imperial Leather portfolio has been extended with a new range of Sweets and Fruits products for bath and shower. The new range of shower and bath products under the Carex brand has performed well in addition to good growth across the core range of handwash products. Original Source has also performed well with new fragrances launched across its range of shower, handwash and body care products.

 

In the beauty division, St Tropez has seen excellent growth its key markets of UK, US and Australia. The gradual tan in shower lotion launched last year has been particularly successful and the range has recently been extended with a darker variant. Further product launches have also taken place across the Sanctuary, Charles Worthington and Fudge brands.

 

Performance in the smaller markets of Poland and Greece has been in line with expectations.

 

Asia

 

In Australia, good performance across Personal Care, Beauty and Food & Nutrition has offset more difficult trading conditions in the Home Care category. Both five:am and Rafferty's Garden have extended their product portfolios during the year with Rafferty's Garden launching into chilled products and continuing its overseas expansion into selected geographies.

 

Indonesia has seen another year of good revenue growth with the entire baby range being completely re-launched in the second half of the year. Further renovation has also taken place across Imperial Leather, Carex and Original Source.

 

Overall performance in the smaller markets of Thailand and the Middle East has been in line with expectations.

 

Africa

 

In Nigeria, all business units are selling relatively well despite a challenging macro environment where consumers are being affected by inflationary pressures. We continue to have market leading brand shares across Personal Care, Home Care, Electricals and Food & Nutrition and product offerings at all price points. In addition, our nationwide distribution and heritage in Nigeria are serving us well in these difficult trading conditions.

 

There continues to be low levels of dollar liquidity in the economy with an additional cost of funding naira from the secondary market. Our focus is on securing materials for the key selling product lines, developing local sourcing to reduce our overall dollar requirements and ensuring relative pricing remains competitive.

 

Overall performance in the smaller markets of Ghana and Kenya has been in line with expectations.

 

Exceptional Charge

 

An exceptional charge of circa £17m is expected in relation to settling a brought forward dollar liability in Nigeria in the secondary market. The charge will be accounted for as it is realised with circa £7m being taken in the year to 31 May 2016.

 

Outlook

 

Performance in Europe and Asia is expected to be strong driven by the continuing brand renovation and innovation programme underpinned by strong cost control.

 

In Nigeria, which represents approximately 25% of group profits, trading conditions are expected to continue to be challenging, with a range of potential outcomes for the new financial year dependent on the translational and transactional impacts of any movement in the naira exchange rate. The Group remains well placed to benefit from its position in Nigeria once growth returns to the market.

 

The Group's balance sheet remains strong and well placed to pursue new opportunities for growth as they arise.

 

Final results

 

Final results for the year ended 31 May 2016 will be announced on Tuesday 26 July 2016.

 

An analysts' presentation will be given at 9:30am on that day. This will be held at the offices of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ. Dial in details will be available immediately following the final results announcement.

 

- ENDS -

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1236

Brandon Leigh - Chief Financial Officer

 

Instinctif Tel: 020 7457 2020

Tim Linacre

Guy Scarborough

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUWRNRNVANRAR
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.